HighTower Advisors »

Inmune Bio Ord shares owned by HighTower Advisors

Quarter-by-quarter ownership of Inmune Bio Ord (INMB) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Inmune Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Inmune Bio Ord held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmune Bio Ord by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $21k 13k 1.63

More positions owned by HighTower Advisors

Apple (AAPL)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Sharkninja Com Shs (SN)
Exxon Mobil Corporation (XOM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)

View all positions for HighTower Advisors

Top funds holding Inmune Bio Ord

Vanguard Capital Management
AQR Capital Management
BlackRock
State Street Corporation
Susquehanna International
Raymond James Financial
Geode Capital Management
Goldman Sachs Group
Millennium Management
Jane Street
Citadel Advisors
UBS Group
Westside Investment Management
Vanguard Fiduciary Trust
Hrt Financial

View all funds holding Inmune Bio Ord